Evoke plc Share Price, Stock Chart and Our Outlook

Evoke plc Share Price and Chart: Understand the Instrument

Prices can move during the trading day, and different market-data services may publish delayed or end-of-day figures. A headline number without a timestamp cannot answer a genuinely live price question. The same applies to a chart whose currency axis is unclear. A price shown as 50 GBX is 50p or £0.50, not £50.

Use the chart's range selector to compare one week, one month, three months, six months, one year or the full available history. The London quotation is in GBX (pence). If the proposed transaction becomes effective, check whether EVOK remains quoted in its present form. Until then, share price, offer value and any cash alternative remain distinct terms.

From 888 Holdings to Evoke: The Same Corporate Lineage, Not a New Casino Stock

888 Holdings changed its corporate name to Evoke plc in May 2024, following shareholder approval. It retained the underlying group and its operating brands, including 888 and William Hill. A search for the 888 Holdings share price or 888 Holdings stock price can therefore lead to historical records of the same corporate lineage. Those searches must not be satisfied with an unlabelled quote from a different security, an unrelated US-traded symbol or the price of Bally's Intralot.

The name change is not itself a share split, a payment to shareholders or a new initial public offering. The 2022 acquisition of William Hill's international operations, subsequent integrations and later strategic review belong to the longer Evoke acquisition history. For this page, the important point is continuity of the listed issuer and the need to verify its current trading status immediately before using any chart.

Share Count, Market Capitalisation and the Equity-Debt Distinction

Evoke's total-voting-rights announcement dated 2 November 2026 stated that, as at 31 October, the company had 450,403,766 ordinary shares carrying one vote each. The nominal value was £0.005 per share. Voting shares are an appropriate reference denominator for ownership notifications; a market-capitalisation calculation additionally requires the correct shares-outstanding basis and a quote from the same valuation date.

The arithmetic is simple: equity market capitalisation = shares outstanding × market price per share. If the quote is in pence, divide by 100 before multiplying into pounds. For illustration of the method only, a hypothetical 40p price applied to 450,403,766 shares would imply approximately £180.2m in equity value. That 40p is not presented as Evoke's observed price, a fair value or a target.

Market capitalisation is not enterprise value. Evoke reported approximately £1,899.4m net debt including leases at 30 June 2026. Analysts sometimes bridge from equity value to enterprise value using net debt and other adjustments, but different definitions, dates, leases and non-controlling interests can change the result. Comparing an equity offer with the full debt burden without stating these differences can be grossly misleading.

The June acquisition announcement valued the entire issued and to-be-issued equity at about £243.1m using a then-assumed share price of Intralot. That is a historical offer-valuation calculation, not the value of Evoke's enterprise and not a current market capitalisation figure. Equity is the residual claim after obligations. Its sensitivity to assumptions can be substantial when the group is highly leveraged.

Does Evoke Pay Dividends or Buy Back Shares?

Evoke's 2024 annual report described a longstanding policy aspiration to distribute 50% of adjusted profit after tax. However, the company announced in April 2022 that it intended to suspend dividends until net leverage fell to 3.0 times or less, or until the board determined an earlier resumption was appropriate. The 2024 report stated the threshold had not been achieved and no dividend would be proposed at the 2025 AGM.

With leverage at 5.6 times in the H1 2026 results and a recommended change-of-control transaction pending, a reader should not assume the historic payout policy means an ordinary dividend is currently due. No independently confirmed new dividend declaration for 2026 is used in this article. A future declaration would require a specific board announcement, record date, payment date and amount; an information portal displaying a historic yield is not sufficient proof.

A shareholder resolution giving directors authority to repurchase stock is not the same thing as a launched programme; neither is equivalent to an RNS confirming purchases on named dates. On the evidence reviewed here, we do not present Evoke as actively returning capital via a current buyback. The board's financing priorities and proposed acquisition are more immediate considerations than an extrapolated dividend yield.

What Do the Results Say About the Strength of the Underlying Business?

Evoke generated £1,781.9m revenue and £356.2m adjusted EBITDA in FY2025, but its statutory loss after tax was £549.1m. The gap matters. Adjusted EBITDA can describe operating performance before financing and various adjustments; it is not distributable cash and cannot erase impairment charges, interest costs or statutory losses.

For the first six months of 2026, Evoke reported £887.5m revenue, £150.2m adjusted EBITDA and a £70.2m statutory loss after tax. Increased gaming duties added about £46m year on year, according to management, with more than half the gross headwind offset by commercial and operating measures. Evoke also reported £85m underlying free cash flow for the period, a company-defined measure that needs reconciliation rather than being treated as unrestricted funds.

Net debt including leases rose from £1,862.7m at the end of 2025 to £1,899.4m at 30 June 2026, while leverage reached 5.6 times. This combination establishes that the group is still generating some operational cash while facing a difficult balance-sheet constraint. We examine the different accounting definitions and segment figures in the Evoke financial results chapter.

The directors' H1 going-concern statement contains two material uncertainties. Without completion of the proposed transaction, Evoke needs materially improved sustainable profits and cash generation to refinance facilities maturing in July 2028 before the January 2028 revolving-facility constraint. If the transaction completes, the present directors lack sufficient visibility over the future owner's intentions and capability to operate the group. They nevertheless judged going-concern accounting appropriate through an assessment period ending September 2027. This is neither a declaration of insolvency nor a guarantee of long-term funding.

The latest official Q3 2026 trading update reported £406m revenue, 7% lower on a reported basis or 2% lower on a like-for-like constant-currency basis. Evoke cited customer-friendly sports results at the start of the football season as a headwind to comparison. A single quarter does not determine the direction of the business, but it is insufficient evidence for declaring a completed turnaround.

Markets and Operating Execution: What Investors Are Exposed to

Evoke owns well-known brands, but a large number of logos does not necessarily produce diversified profit. FY2025 group reporting identified UK Retail as 28% of revenue and UK Online as 36%, with Italy at 12%, Spain 6%, Romania 4%, Denmark 3% and other markets accounting for the balance. The exact mix reflects the FY2025 reporting period; it should not be mistaken for a current share-price factor measured daily.

The UK government's April 2026 Remote Gaming Duty increase from 21% to 40% directly pressured online casino economics. Additional tax changes scheduled or proposed for 2027 could affect other betting and machine-game activities. Evoke responded with marketing restraint, cost action and a smaller shop estate. By 30 June 2026 the business had 1,024 shops, versus 1,302 a year earlier. Like-for-like retail trends improved, but reported retail sales declined as the estate shrank.

From an equity perspective, the question is whether those adjustments yield durable cash after duties and capital spending. Underinvestment can protect liquidity today yet weaken the customer proposition tomorrow. A better-than-expected operating result could therefore improve business resilience while having a limited effect on Evoke shares if the transaction consideration is the dominant valuation anchor. The wider risk and opportunity assessment explores that trade-off.

Bally's Intralot: Share Consideration Is Not a Fixed Cash Offer

The recommended acquisition announced on 5 June 2026 is the decisive corporate event for the listed security. The principal shares offer is 0.537 new Bally's Intralot shares for each Evoke share, subject to the scheme becoming effective and its terms. The original announcement valued that ratio at approximately 52p per Evoke share, using a Bally's Intralot share price of €1.12 at the time. That quoted figure is a dated calculation, not a guaranteed 52p cash proceeds figure for every shareholder.

An alternative offers 52p in cash per Evoke share for eligible shareholders making valid elections, but the aggregate cash available is capped at £117.1m. The official terms set out allocation and potential scaling where elections exceed availability, as well as restrictions applicable to certain overseas shareholders. A shareholder must therefore distinguish the default share exchange from an eligible election into a limited cash pool. The offer document, not a headline, governs actual entitlement.

There is also currency and market risk. The value of 0.537 newly issued Intralot shares in sterling depends on the relevant share price and exchange rate, subject to the final scheme provisions. The original 52p reference cannot be projected forward without updating those inputs. Once the scheme becomes effective, Evoke shareholders receiving stock would hold a security with a different issuer, trading venue and risk profile.

On 23 October 2026, Evoke said the relevant shareholders had approved the required resolutions and most regulatory approvals had arrived, but some conditions remained outstanding. The expected completion window was late Q4 2026 or early Q1 2027. Shareholder approval alone is not the same as the scheme becoming legally effective. A court-sanctioned scheme also has procedural requirements, and the listing status must be checked on the actual effective date.

Completion could refinance certain July 2028 debt tranches through planned transaction funding, subject to conditions; failure to complete would leave Evoke needing another financing solution. The transaction is therefore both a shareholder-consideration event and a balance-sheet event. The legal mechanics also matter: Evoke is Gibraltar-incorporated, and its official offer information explains that the UK Takeover Panel's Code does not apply to it in the ordinary statutory manner. Readers should consult official scheme documents for their own legal rights.

Our Outlook: Business Resilience versus Attractiveness of the Shares

Our analytical horizon is the next 12 - 24 months from 5 November 2026. This is our editorial timeframe, not management guidance or an expected holding period. Our central judgement is cautious: Evoke has proven brands and identifiable cost levers, but high leverage, tax exposure and two disclosed going-concern uncertainties limit the confidence with which its standalone equity can be valued. Equally, a proposed share exchange makes a simple earnings-multiple target less useful than checking the actual security and transaction terms.

We do not provide a numerical target price. That would require a verified same-date EVOK quote, share count, deal valuation assumptions, current Intralot quote and exchange rate, and a transparent probability framework that the available evidence does not justify. Even with those inputs, a target would be a scenario estimate, not a promised outcome.

Our stance would become more constructive on evidence of sustained post-duty cash generation and a settled, serviceable capital structure. It would become more negative if liquidity headroom deteriorated or the proposed acquisition failed without an executable funding alternative. There is also a counterargument to excessive pessimism: positive adjusted segment performance and the willingness of the acquiring group to undertake a complex transaction suggest that the operating assets retain value. The question is how that value is divided among creditors and the different classes of shareholder claims.

Ultimately, a business can be resilient enough to operate and yet offer unattractive equity economics at a particular price. Conversely, low market capitalisation is not, by itself, evidence of a bargain when debt and transaction conditions are material. We distinguish these judgments rather than converting a news headline into an investment instruction.

Quick Questions About Evoke Shares